Vertex Pharmaceuticals Inc. announced today that it submitted a New Drug Application to the U.S. Food and Drug Administration for the approval of the first triple-combination therapy for cystic fibrosis.
Site Search
Showing 1 - 10 of 125 results
News
|
May 6, 2011
|
1 min read
News
|
July 22, 2019
|
1 min read
News
|
Nov. 8, 2011
|
2 min read
Yesterday, President Donald J. Trump signed the Right to Try bill into law. The House approved the bill last week and the Senate passed it last summer.
News
|
May 31, 2018
|
3 min read
The New England Journal of Medicine, the world's most influential and widely read medical periodical, features a study this week about a Phase 2 clinical trial of VX-770, an oral drug in development that targets the root cause of cystic fibrosis.
News
|
Nov. 17, 2010
|
3 min read
News
|
Sept. 16, 2008
|
1 min read
News
|
April 11, 2008
|
1 min read
News
|
Aug. 20, 2008
|
1 min read
News
|
Sept. 26, 2008
|
1 min read
News
|
June 29, 2009
|
1 min read